Journal Pre-proof Identification of hyperglycemia-associated microbiota alterations in saliva and gingival sulcus Yu-Shan Wei, Ya-Chun Hsiao, Guan-Wei Su, Yi-Ru Chang, Hsiu-Pin Lin, Yi-Shiuan Wang, Yi-Ting Tsai, En-Chi Liao, Hsin-Yi Chen, Hsiu-Chuan Chou, Mei-Lan Ko, WenHung Kuo, Shing-Jyh Chang, Wen-Chi Cheng, Hong-Lin Chan PII:
S0003-9861(19)30991-9
DOI:
https://doi.org/10.1016/j.abb.2020.108278
Reference:
YABBI 108278
To appear in:
Archives of Biochemistry and Biophysics
Received Date: 4 November 2019 Revised Date:
27 December 2019
Accepted Date: 20 January 2020
Please cite this article as: Y.-S. Wei, Y.-C. Hsiao, G.-W. Su, Y.-R. Chang, H.-P. Lin, Y.-S. Wang, Y.-T. Tsai, E.-C. Liao, H.-Y. Chen, H.-C. Chou, M.-L. Ko, W.-H. Kuo, S.-J. Chang, W.-C. Cheng, H.-L. Chan, Identification of hyperglycemia-associated microbiota alterations in saliva and gingival sulcus, Archives of Biochemistry and Biophysics (2020), doi: https://doi.org/10.1016/j.abb.2020.108278. This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. © 2020 Published by Elsevier Inc.
Author Contributions Statement Hong-Lin Chan and Wen-Chi Cheng conceived of the presented idea. Ya-Chun Hsiao, Guan-Wei Su and Yi-Ru Chang verified the analytical methods. Yu-Shan Wei wrote the main manuscript text and prepared all figures with support from Hsiu-Pin Lin and Yi-Shiuan Wang. Hsiu-Chuan Chou, Yi-Ting Tsai, En-Chi Liao, Hsin-Yi Chen, Mei-Lan Ko, Wen-Hung Kuo and Shing-Jyh Chang, helped supervise the project. All authors discussed the results and contributed to the final manuscript.
1
Identification of hyperglycemia-associated microbiota alterations in saliva and
2
gingival sulcus
3 4
Yu-Shan Wei1, Ya-Chun Hsiao2, Guan-Wei Su3, Yi-Ru Chang4, Hsiu-Pin Lin4,
5
Yi-Shiuan Wang1, Yi-Ting Tsai1, En-Chi Liao1, Hsin-Yi Chen1, Hsiu-Chuan Chou5,
6
Mei-Lan Ko5,6, Wen-Hung Kuo7, Shing-Jyh Chang8, Wen-Chi Cheng3,*, and
7
Hong-Lin Chan9,*
8 9
1
Institute of Bioinformatics and Structural Biology, National Tsing Hua University,
10
Hsinchu, Taiwan
11
2
Department of endocrinology and metabolism, Hsinchu Mackay Memorial Hospital
12
3
Dental department of Hsinchu Mackay memorial hospital
13
4
General Biologicals Corporation, Hsinchu, Taiwan
14
5
Department of Biomedical Engineering and Environmental Sciences, National Tsing
15
Hua University, Taiwan
16
6
17
Branch, Hsinchu 300, Taiwan.
18
7
Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan
19
8
Department of Obstetrics and Gynecology, Hsinchu MacKay Memorial Hospital,
20
Hsinchu, Taiwan
21
9
22
Science, National Tsing Hua University, Hsinchu, Taiwan
Department of Ophthalmology, National Taiwan University Hospital Hsin-Chu
Institute of Bioinformatics and Structural Biology and Department of Medical
23 24 25 26 1
27
*Correspondence to:
28
Dr. Hong-Lin Chan, Institute of Bioinformatics and Structural Biology & Department
29
of Medical Science, National Tsing Hua University, No.101, Kuang-Fu Rd. Sec.2,
30
Hsinchu, 30013, Taiwan. Tel: 886-3-5742476; Fax: 886-3-5715934; E-mail:
31
[email protected]
32
Dr. Wen-Chi Cheng, General Biologicals Corporation, No. 6, Innovation First Road,
33
Hsinchu Science Park, Hsinchu 30076, Taiwan. Tel: (+886)-3-577-9221 ext. 270; Fax:
34
886-3-577-9227; E-mail:
[email protected]
35 36
Keywords: MALDI-TOF mass spectrometry, Oral Microbiology, Hyperglycemia
37
2
38 39
Identification of hyperglycemia-associated microbiota alterations in saliva and gingival sulcus
40 41
Abstract
42
Oral microbes are a contributing factor to hyperglycemia by inducing an increase
43
in insulin resistance resulting in uncontrolled blood glucose levels. However, the
44
relationship between the distribution of oral flora and hyperglycemia is still
45
controversial. Combining the power of MALDI-Biotyper with anaerobic bacterial
46
culture, this study explores the correlation between anaerobic bacteria in the oral
47
cavity and blood glucose levels. The results demonstrated that altered blood glucose
48
levels contributed to a varied bacterial distribution in the oral cavity. Specifically,
49
Veillonella spp. and Prevotella spp. were identified in a higher proportion in people
50
with elevated blood glucose levels. Six bacterial species identified in this study
51
(Prevotella
52
Streptococcus mitis, Streptococcus salivarius, and Veillonella parvula) not only
53
demonstrated a positive association with higher blood glucose levels, but also likely
54
contribute to the development of the condition. The data demonstrated MALDI-TOF
55
MS to be a simpler, faster, and more economical clinical identification tool that
56
provides clarity and depth to the research on blood glucose and oral microbiota.
melaninogenica,
Campylobacter
57 3
rectus,
Streptococcus
gordonii,
58
Introduction
59
Oral microbes play an important role in the human health. The synergy between
60
oral microbes and the body helps in the defense against external stimuli. However, an
61
imbalance in the oral microbiome can lead to a number of oral diseases, such as dental
62
caries, periodontitis, periodontal disease, oral cancer [1], in addition to other systemic
63
diseases affecting the gastrointestinal, nervous, cardiovascular, endocrine, and
64
immune systems [2, 3]. Specifically, oral microbes have been reported as one of the
65
factors causing hyperglycemia. Studies indicate that oral microbes induce an increase
66
in insulin resistance leading to uncontrolled blood glucose levels [4, 5]. Two
67
indicators commonly used by diabetics to monitor glycemic status are fasting blood
68
glucose (GluAC) and glycated hemoglobin (HbA1c). The GluAC levels reflect
69
short-term glycemic changes whereas HbA1c signify long-term (2-3 months) blood
70
glucose levels [6, 7]. An increase in blood glucose results in a concomitant rise in the
71
glucose concentration in the gingival space [8, 9], possibly affecting the oral
72
microbiome distribution [10, 11]. Previous studies have demonstrated that, compared
73
to people with lower blood glucose levels, those with higher blood glucose levels
74
have
75
Capnocytophaga, Campylobacter, Eikenella, Fusobacterium, Gemella, Neisseria,
76
Parvimonas,
77
Terrahemophilus, Tannerella, TM7, Veillonella, and lower proportions of Eubacterium,
a
higher
proportion
of
Peptostreptococcus,
members
of
Leptotrichia,
4
Aggregatibacter,
Selenomonas,
Actinomyces,
Streptococcus,
78
Filifactor, Porphyromonas, Prevotella, Pseudomonas, Synergistetes, Tannerella and
79
Treponema [11-15]. At the species level, Eikenella corrodens, Fusobacterium
80
nucleatum, Prevotella intermedia, Streptococcus agalactiae, Treponema denticola,
81
Veillonella parvula, and V. dispar were identified more frequently in populations with
82
poor glycemic indices [10, 12-14]. However, some studies indicated that the
83
proportion of P. gingivalis and Tannerella forsythia is higher in subjects with healthy
84
blood glucose status compared to those with a poor one, in contrast to studies that
85
reported the opposite. Furthermore, other groups identified no correlation between the
86
distribution of P. gingivalis and T. denticola, and blood glucose levels [13, 15-20].
87
Therefore, the impact of blood glucose status on the oral bacterial flora is still
88
inconclusive [10, 11].
89
In the previous reports, identification of the microorganisms in the correlation
90
studies between oral microbiota and glycemic states was performed using classical
91
laboratory procedures, such as checkerboard DNA-DNA hybridization, polymerase
92
chain reaction, and 16S rDNA Sanger sequencing. In these studies, MALDI BioTyper
93
was frequently used to identify clinical pathogens, such as pathogens in the blood,
94
urine, intestinal tract, and oral cavity [21-26]. The advantage of MALDI TOF MS for
95
identifying microorganisms compared to conventional identification methods is that
96
the identification can be achieved without any prior knowledge of the taxonomic 5
97
affiliation [27-29], in addition to being more economical, rapid and accurate [25, 29,
98
30]. The MALDI BioTyper obtains the microbial identification information by
99
comparing the test sample spectra with the reference spectra in the database, using
100
scoring algorithms [21]. Several studies have demonstrated the efficacy of the
101
MALDI-Biotyper for accurate species-level identification at a rate greater than 70%
102
[31-33].
103
The conflicting reports on the relationship between blood glucose status and oral
104
microbiota warrant further research [10, 11]. In addition, the primary group of
105
pathogenic bacteria in the oral cavity were anaerobic [34]. Therefore, this study
106
combined the advantages of MALDI-Biotyper with anaerobic cultivation of bacteria
107
in order to explore the correlation between the anaerobes in the mouth and blood
108
glucose levels. By investigating the correlation between blood glucose monitoring
109
indicators and anaerobic bacteria, we can find anaerobic microbial distribution that
110
are affected by blood glucose and potentially cause blood glucose to be uncontrolled.
111 112 113 114 115 6
116 117 118 119
Materials and methods
120 121
Settings and Participants
122
The participants in the study were enrolled from a single institution: Mackay
123
Memorial Hospital in Hsinchu, Taiwan. The protocol approval (No: NCT03351530,
124
November 24, 2017) was obtained from Mackay Memorial Hospital Institutional
125
Review Board on February 10th, 2017, and informed written consent was obtained
126
from all participants. All methods were performed in accordance with the relevant
127
guidelines and regulations. General inclusion criteria were as follows: >30 years of
128
age, no use of systemic antibiotics or anti-inflammatory drugs in the 6 months prior to
129
enrollment, and no use of immunological agents in the previous 3 months, except
130
hypoglycemic agents for diabetes control. Oral inclusion criteria were average
131
probing depth (PD) < 6 mm and all subjects had at least 16 teeth. The exclusion
132
criteria included pregnancy, use of birth control pills, severe systemic diseases
133
(hepatitis, acquired immune deficiency syndrome), and a previous history of smoking
134
and/or betel nut use. 7
135 136
Sample collection
137
Saliva and gingival sulcus samples were collected from all participants. The
138
participants did not refrain from eating before collection, but rinse their mouth with
139
water for five seconds and discard were required before collection. The saliva used in
140
this study was unstimulated saliva and the cells were not removed from the entire
141
saliva[35]. For saliva collection, participants were asked to spit 3 ml saliva into a
142
15-mL sterilized tube. Gingival sulcus samples were collected with two sterilized
143
paper points each participant. Immediately after collection, the samples were
144
transferred to a CMPTM Anaerobic TranSwab container and stored at 4°C. After
145
removal from the CMPTM Anaerobic TranSwab, all samples were transferred into
146
Tryptic soy broth (TSB), and mixed with glycerol in a 1:1 ratio, and stored at -80°C
147
immediately. Ten-fold serial log dilutions of the sample were then prepared: 20× to
148
2,000,000× dilutions (beginning from 2 × 10-1 to 2 × 10−6) of the saliva samples, and
149
2× to 2,000× dilutions (beginning from 2 to 2 × 10−3) of the gingival sulcus samples.
150
The diluted samples (100 µL) were pour-plated onto pre-reduced Anaerobic Blood
151
Agar (TSB with 0.5% yeast extract, 0.05% cysteine HCl-H2O, 0.5 mg/ml hemin and
152
2 µg/ml vitamin K1) and Chocolate agar for anaerobic incubation (anaerobic gas
153
mixture, 80% N2, 10% CO2, 10% H2, 37 °C, 4 days) in a Whitley DG250
154
Workstation.
155 156
Microbial identification and quantification: Identification by MALDI-TOF MS
157
analysis
158
All bacterial colonies from both medium were transferred to a target polished 8
159
steel plate (MBT 384, Bruker Daltonics Inc.). The proteins from the colonies were
160
extracted with one microliter of 70% formic acid (Sigma). After air-drying, they were
161
overlaid with one microliter of a matrix solution (10 mg/ml solution of
162
α-cyano-4-hydroxycinnamic acid (HCCA), in a mixture of 50% acetonitrile, 47.5%
163
ultra-pure water, and 2.5% trifluoroacetic acid). After repeated the air-drying process,
164
the samples were analyzed on an Autoflex III MALDI-TOF mass spectrometer
165
(Bruker Daltonik GmbH, Leipzig, Germany). The range of spectra (between 2000 to
166
20,000 Da) was recorded at the maximal laser frequency. The raw spectra were
167
analyzed automatically using the MALDI BioTyper 3.1 software package (default
168
settings; Bruker Daltonik GmbH, Bremen, Germany, BioTyper® database renewed at
169
2018/5/15). Approximately 7311 main spectra profile (MSP) were detected. The log
170
scores obtained ranged from 0 to 3.00, which conformed to the criteria recommended
171
by the manufacturer. A score of ≥ 1.7 was considered as the ‘confidence identification’
172
cutoff, below which scores were considered unreliable for protein identification. Each
173
sample had greater than 100 colonies that could be reliably identified.
174 175
Data sources and measurement
176
Colonies that met the confidence identification scores were counted and
177
represented with the number of resulting colonies (colony-forming units, or CFU) as 9
178
means and standard deviation of the means (SD). Statistical significance was
179
determined using the Mann-Whitney Statistical test (P < 0.05) on the GraphPad Prism
180
7 Software. Shannon diversity index [36-38] was calculated as followed: Shannon -
181
Wiener Index (H'); H' = - ∑ (pi x ln (pi)); N = Number of all individuals in
182
genus/species; ni = Number of individuals in genus/species; pi = the proportion of
183
individuals in the genus/species (pi = ni / N). Pearson correlation was used to analyze
184
the association between all studied parameters using IBM SPSS Statistics. P values <
185
0.05 were considered statistically significant.
186 187
Results
188
Demographic and clinical data of participants
189
Of the 25 study participants, the GluAC levels of 11 and 14 participants was
190
<100 mg/dL (average 94.5. ±3.8 mg/dL) and >100 mg/dL (140.3±44.2 mg/dL),
191
respectively. The corresponding HbA1c levels were 5.5±0.3% and 6.6±1.0%,
192
respectively (P< 0.05, Mann-Whitney). The demographic characteristics between
193
these two groups, including age, waist circumference, and body mass index (BMI)
194
were similar (Table 1).
195
In order to study the differences in the anaerobic bacterial oral flora as a result of
196
changes in the blood glucose level, the bacteria cultured in the anaerobic environment 10
197
were identified by MALDI Biotyper. This study analyzed the anaerobic bacterial
198
distribution in saliva samples and gingival sulcus samples by MALDI BioTyper. A
199
total of 37 bacterial genera comprising of 87 unique species were identified in this
200
study.
201 202
Association of glycemic states with anaerobic bacterial genera identified by the
203
MALDI BioTyper
204
In order to investigate the relationship between anaerobic microbial diversity and
205
blood glucose status, the MALDI Biotyper was used to analyze the distribution of
206
anaerobic bacteria isolated from saliva or gingival sulcus samples. First, Shannon
207
diversity index was used to calculate the diversity at the genus level, but revealed no
208
statistical differences between the two populations (between 100 mg/dl), in both
209
saliva and gingival sulcus samples (Figure 1). Although there was no statistical
210
significance found in the results, the pattern still showed a positive tendency (Table 2
211
and Figure 2a,b, e,f).
212
The distribution of the bacterial genera in saliva and gingival sulcus fluid is
213
shown in Figure 3 and Figure 4, respectively. The abundance of each bacterial genera
214
is indicated by the area of the circles. The eleven columns on the left represent the
215
distribution of bacterial genera from participants with GluAC <100 mg/dL whereas 11
216
the rightmost column represents the distribution of the genera of patients with GluAC
217
>100 mg/dL. The main anaerobic genera in saliva and gingival sulcus fluids were
218
Streptococcus (relative abundance: 36.3–95.0% (saliva); 4.1–89.5% (gingival sulcus)),
219
Actinomyces (relative abundance: 0.4–34.8% (saliva); 0–54.9% (gingival sulcus)), and
220
Veillonella (relative abundance: 0.3–24.2% (saliva); 0-13.2% (gingival sulcus)).
221
The association between blood glucose status and oral anaerobic genera analyzed
222
in this study revealed no statistically significant correlation, as seen by the Shannon
223
diversity index (Figure 1, 2a,b, e,f and Table 2). Therefore, the correlation between
224
the distribution of the genera in the saliva and gingival sulcus fluid obtained by the
225
anaerobic culture method and the MALDI Biotyper technique was analyzed. The
226
Pearson correlation coefficient analysis of the two datasets identified five bacterial
227
genera associated with elevated GluAC levels: Campylobacter spp. (0.592, P=0.026*),
228
Porphyromonas spp. (0.992, P<0.001***), Prevotella spp. ( 0.661, P=0.014*), Rothia
229
spp. (0.938, P=0.018*), and Veillonella spp. (0.602, P=0.006**; Table 3). Among
230
them, Porphyromonas spp. also had a positive correlation with HbA1c levels (Pearson
231
correlation coefficient: 0.893, p=0.017*; Table 3). The five genera associated with
232
blood glucose status may represent a factor influencing the pathogenesis of poor
233
glycemic states.
234 12
235
Association of glycemic states with anaerobic bacterial species identified by MALDI
236
BioTyper
237
Comparison of the Shannon diversity indices in the species level samples of
238
saliva and gingival sulcus revealed a significant difference between the two
239
populations (P< 0.05, Mann-Whitney) (Figures 1). The Shannon diversity index for
240
the species level analysis data of saliva samples for participants with GluAC >100
241
mg/dL and <100 mg/dL was 1.81 ± 0.43 and 2.24 ± 0.21 (P = 0.0152*), respectively.
242
The Shannon diversity in species level in gingival sulcus samples was 1.54 ± 0.49
243
(>100 mg/dL GluAC group) and 1.97 ± 0.38 (<100 mg/dL GluAC group;P =
244
0.0038**). In addition, the Pearson correlation coefficient was used to investigate the
245
relationship between glycemic states and Shannon diversity index in species level.
246
The Shannon diversity index in species level of saliva positively correlated with
247
GluAC and HbA1c (correlation coefficient 0.427, p=0.033*; 0.556, p=0.004**,
248
respectively; Table 2 and Figure 2). The results suggest that the diversity of anaerobic
249
bacteria at the species level may be impacted by blood glucose levels and showed an
250
increase with increasing blood glucose concentrations.
251
The distribution of species in saliva and gingival sulcus were identified from the
252
anaerobic culture followed by MALDI Biotyper-based analysis. The correlation
253
between blood glucose status and the oral anaerobic microbial species was then 13
254
investigated using Pearson correlation coefficient. The distribution of the species of
255
saliva and gingival sulcus fluid is shown in Figure 5 and Figure 6, respectively. The
256
bacterial abundance of each species corresponds to the area of the circle. The eleven
257
columns on the left and the fourteen columns on the right indicate the distribution of
258
the species from participants with GluAC <100 mg/dL and >100 mg/dL, respectively.
259
The main anaerobic species identified in saliva were Streptococcus pneumoniae
260
(relative
261
Streptococcus parasanguinis (0–14.8%). The main anaerobic bacteria identified in the
262
gingival sulcus fluid were Streptococcus oralis (relative abundance: 0–64.5%),
263
Streptococcus pneumoniae (0–22.9%), and Veillonella parvula (0–14.1%; Figures 5
264
and 6).
abundance:
0–58.5%),
Streptococcus
salivarius
(0–52.4%),
and
265
At the species level identification, seven species were associated with GluAC:
266
Prevotella melaninogenica (Pearson correlation coefficient 0.914, P=0.03*),
267
Campylobacter
268
P=0.001**), Streptococcus gordonii (0.772, P=0.009**), Streptococcus mitis (0.693,
269
P=0.013*), Streptococcus salivarius (0.909, P=0.012*), and Veillonella parvula
270
(0.518, P=0.033*). Among them, three species were associated with HbA1c:
271
Prevotella melaninogenica (Pearson correlation coefficient: 0.959, p=0.001**),
272
Porphyromonas gingivalis (0.960, p=0.040*), and Streptococcus mitis (0.652,
rectus
(0.705,
P=0.03*),
14
Porphyromonas
gingivalis
(0.999,
273
p=0.022*; Table 4). The tendency of an increased abundance of glycemic
274
state-associated bacteria in oral samples might predispose the individual to a greater
275
risk of uncontrolled blood glucose.
276 277
Discussion
278
Previous studies have reported that when the blood glucose rises, the glucose
279
concentration in the gingival sulcus also increases affecting the microbial distribution
280
in the oral cavity [8-11]. However, conflicting studies identified that hyperglycemia
281
does not affect the microbial distribution in the oral cavity [39]. Thus, the influence of
282
blood glucose on the distribution of oral microbes is an open question and a subject of
283
active research [10, 11]. The current study attempted to answer whether blood glucose
284
levels affect the distribution of oral microbial flora using the MALDI-TOF MS to
285
identify anaerobic microorganisms from saliva and gingival sulcus samples. A total of
286
25 participants were enrolled in this study and 37 genera of bacteria including 87
287
strains were identified in the oral specimens. We also determined the total bacterial
288
counts, microbial diversity and Pearson correlation coefficient for the samples. Our
289
results demonstrated that in both saliva and gingival sulcus samples, the population
290
with a higher blood glucose concentration displayed greater anaerobic bacterial
291
species diversity compared to the population with lower blood glucose concentration. 15
292
In addition, the anaerobic bacterial diversity had a positive Pearson correlation
293
coefficient with blood glucose concentration regardless of the identification level or
294
sample type. In summary, the data demonstrated that the diversity of anaerobic
295
bacteria is positively correlated with blood glucose concentrations. Advancing
296
previous studies, which identified that hyperglycemics have a higher abundance of
297
anaerobic bacteria than normoglycemics [11], our results revealed that high blood
298
glucose also diversified the anaerobic microbial flora. One potential reason for the
299
increased diversity of the anaerobic flora may be due to the different
300
microenvironments caused by the differences in blood glucose, resulting in the
301
proliferation of microorganisms with different growth requirements in specific oral
302
niches. The microenvironment of hyperglycemia can attract microorganisms that have
303
a higher demand for glucose. After initial colonization by these microorganisms that
304
potentially generate conducive conditions, others that depend on the growth of the
305
primary
306
concentration-dependent alterations in the oral microbial composition [10, 11].
microorganisms
will
proliferate,
resulting
in
a
blood
glucose
307
In all, 37 unique genera were identified in this study, of which Pearson
308
correlation coefficient analysis identified a positive correlation with blood glucose
309
concentration for five genera: Campylobacter spp., Porphyromonas spp., Prevotella
310
spp., Rothia spp., and Veillonella spp. This is in agreement with previous studies that 16
311
identified Veillonella spp. at a higher proportion in the oral cavity of people with
312
hyperglycemia [10, 11, 13, 15]. Interestingly, Veillonella spp. was mostly reported to
313
be present in healthy periodontal states [13, 40][41]. In agreement with previous
314
reports, our data identified a positive correlation between both Veillonella parvula and
315
Prevotella spp., and elevated blood glucose levels [10, 13]. Members of both of the
316
genera Veillonella spp. and Prevotella spp. can utilize carbohydrates [10]. A potential
317
scenario based on our data is that when the glucose in the blood increases, the
318
environment changes to stimulate the growth of the genera that preferentially utilize
319
carbohydrates [9, 13]. This might be the reason for the selective increase in the
320
richness of Veillonella spp., Prevotella spp in the anaerobic oral microbiota.
321
Our MALDI-TOF MS analysis identified 87 unique anaerobic bacterial species,
322
of which seven were positively associated with varying blood glucose status, as
323
determined
324
Campylobacter
325
Streptococcus mitis, Streptococcus salivarius, and Veillonella parvula. Among them,
326
Porphyromonas gingivalis has been extensively studied. Although the results of our
327
study are consistent with previous results that found the population with higher blood
328
glucose had a higher trend of richness of P. gingivalis in the oral cavity [12, 40, 42],
329
other studies have reported conflicting data [11, 13-15, 17]. The reasons for the
by
Pearson rectus,
correlation
analysis:
Porphyromonas
17
Prevotella
gingivalis,
melaninogenica,
Streptococcus
gordonii,
330
differences in the distribution of strains are still unclear. Some reports indicate that the
331
distribution of microbial flora can be affected by differences in lifestyle and
332
geographical location [15, 43, 44].
333
In addition to differences in geography and living position, there are some
334
limitations that constrained our research. Due to the study exclusion criteria, we
335
enrolled relatively few participants. We excluded people who used systemic
336
antibiotics or anticancer drugs in the past six months, pregnant women, those
337
suffering from systemic diseases such as hepatitis or acquired immunodeficiency
338
syndrome, smokers, and betel nut users. Moreover, at least 16 teeth for a participant
339
were required for inclusion in this clinical trial. However, it’s difficult to meet this
340
requirement for participants with hyperglycemia. With a higher sample number, there
341
will probably be an increase in the credibility of these potential bacteria and obviate
342
the statistical limitations of small sample numbers. In spite of this limitation, the data
343
identified the anaerobic flora in saliva and gingival sulcus by MALDI-TOF MS.
344
Further, the data suggests that the distribution of the flora cultured in the anaerobic
345
environment varies with the blood glucose concentration, and this change may be due
346
to changes in the oral environment resulting in the proliferation of certain bacterial
347
groups [9, 13]. In addition to the limited number of samples, sample preservation and
348
culture techniques were also potential constraints. In this study, the anaerobic 18
349
sampling tube (CMPTM Anaerobic TranSwab container) was used to preserve the
350
samples immediately after sampling, stored at 4 °C, and processed in an anaerobic
351
console (Whitley DG250 Workstation) within 24 hours of collection. In spite of all
352
these precautions, it is still impossible to avoid the loss of some sensitive bacteria
353
post-sampling, after leaving the original oral environment. Furthermore, due to the
354
bacterial diversity in the samples, growth conditions for revival are also diverse. In
355
this study, only two media (anaerobic blood Agar and chocolate agar) were used.
356
Although 87 different species were identified, other media conditions need to be
357
considered in the future. Diverse culture conditions are added to increase the variety
358
of bacteria identified by the experiment. Another factor that can be varied is the
359
incubation time. Although some studies indicate that culture time does not affect the
360
identification rate [45, 46], time is still an important factor in the process of
361
cultivating microorganisms [47]. Finally, technical limitations undoubtedly play a role.
362
The use of MALDI-TOF MS to identify microorganisms relies on the number and
363
quality of reference spectra in the database. Therefore, identification of strains that do
364
not exist in the database is not possible. However, the MALDI-TOF bacterial database
365
is still expanding and many studies have used MALDI-TOF MS to identify
366
microorganisms [26, 47-49]. A recent report identifying the players in microbial
367
communities in peri-implantitis pockets also showed that MALDI-TOF MS is an asset 19
368
in studying disease-related oral microbiota [50]. Therefore, even in the current
369
scenario, MALDI-TOF MS is fast, sensitive, and more economical than the classical
370
laboratory procedures used to study the relationship between oral microbes and blood
371
glucose status [51-53]. However, the expansion of the MALDI-TOF database and the
372
establishment of the in-house MALDI-TOF MS libraries are still indispensable and
373
will help the development of microbe-related research, improve the accuracy of
374
microbial identification, and help identify complete microbiotas [47, 49, 50, 54, 55].
375
One of the complementary method to MALDI-TOF-based microbiota analysis, is
376
RNA sequencing analysis (RNA-Seq) which has become a standard strategy for
377
analyzing whole bacterial transcriptome and metatranscriptome information[56].
378
Besides, MS-based instruments, such as gas chromatography-mass spectrometry
379
(GCeMS), and liquid chromatography-mass spectrometry (LC-MS), might resolve the
380
whole metabolite patterns of the microbiome in the future.
381
In this study, MALDI-TOF MS for microbial identification was used to
382
investigate the distribution of oral flora under different blood glucose concentrations.
383
Veillonella spp. and Prevotella spp. were identified at a higher proportion in people
384
with higher blood glucose levels, corroborating several previous studies. The data also
385
showed differences in bacterial distribution due to differences in the physiological
386
environment and that Veillonella spp. and Prevotella spp. may play a certain role in 20
387
patients with higher blood glucose levels. In addition, other species identified in this
388
study that were positively associated with blood glucose, namely Prevotella
389
melaninogenica, Campylobacter rectus, Streptococcus gordonii, Streptococcus mitis,
390
Streptococcus salivarius, and Veillonella parvula, also have the potential to participate
391
in the pathogenesis, resulting in higher blood glucose levels. Our results also
392
demonstrate that with the expansion of the bacterial database, MALDI-TOF MS will
393
be a simpler, faster, and more economical clinical identification tool, providing clarity
394
and comprehensiveness to the research on blood glucose levels and oral microbial
395
flora.
396 397
Author Contributions Statement
398
Hong-Lin Chan and Wen-Chi Cheng conceived of the presented idea. Ya-Chun Hsiao,
399
Guan-Wei Su and Yi-Ru Chang verified the analytical methods. Yu-Shan Wei wrote
400
the main manuscript text and prepared all figures with support from Hsiu-Pin Lin and
401
Yi-Shiuan Wang. Hsiu-Chuan Chou, Yi-Ting Tsai, En-Chi Liao, Hsin-Yi Chen,
402
Mei-Lan Ko, Wen-Hung Kuo and Shing-Jyh Chang, helped supervise the project. All
403
authors discussed the results and contributed to the final manuscript.
404 405
Funding 21
406 407
This work was funded by R&D Piloting Cooperation Projects between Industries and Academia 104A19 and 105A24
408 409
Additional Information
410
All authors: none to declare.
411 412
Additional information
413
Competing Interests: The authors declare no competing interests.
414 415
22
416 417
Figure legends
418
Figure 1: Shannon Diversity Index at the genus and species level for the different
419
sites. (a) Samples from saliva. (b) Samples from gingival sulcus.
420 421
Figure 2: Correlation of glycemic states, fasting blood glucose (GluAC) and
422
glycated hemoglobin (HbA1c) with Shannon Diversity Index at the genus and
423
species level. Correlation of GluAC with Shannon Diversity Index at the genus level
424
of samples from (a) saliva (b) gingival sulcus, and at the species level of samples from
425
(c) saliva (d) gingival sulcus. Correlation of HbA1c with Shannon Diversity Index at
426
the genus of samples from (e) saliva (f) gingival sulcus, and at the species of samples
427
from (g) saliva (h) gingival sulcus.
428 429
Figure 3: The distribution of the genera identified by MALDI BioTyper of saliva
430
from participants. The y-axis shows the genera identified by MALDI BioTyper of
431
saliva. The relative abundance of each genus is indicated by the area of the circles.
432
Each of the 25 columns represents the profile of an individual participant in this study.
433 434
Figure 4: The distribution of the genera identified by MALDI BioTyper of 23
435
gingival sulcus from participants. The y-axis shows the genera identified by
436
MALDI BioTyper of gingiva. The relative abundance of each genus is indicated by
437
the area of the circle. Each of the 25 columns represents the profile of an individual
438
participant in this study.
439 440
Figure 5: The distribution of the species identified by MALDI BioTyper of saliva
441
from participants. The y-axis shows the species identified by MALDI BioTyper of
442
saliva. The relative abundance of each genus is indicated by the area of the circle.
443
Each of the 25 columns represents the profile of an individual participant in this study.
444 445
Figure 6: The distribution of the species identified by MALDI BioTyper of
446
gingival sulcus from participants. The y-axis shows the species identified by
447
MALDI BioTyper of gingival sulcus. The relative abundance of each genus is
448
indicated by the area of the circle. Each of the 25 columns represents the profile of an
449
individual participant in this study.
450 451 452 453 24
Table 1 Demographic and clinical data of participants Subjects
25
Glycemic states (mg/dL) Subjects
≧ 100
< 100
GLU-AC
P value
11
44%
14
56%
9
82%
8
57%
Females (N, %) Age (years)
46.3 ± 10.8
53.3 ± 12.8 0.1
Waistline (cm)
81.3 ± 8.7
90.7 ± 12.7 0.11
BMI
23.6 ± 3.5
26.1 ± 5.2
0.27
Glycemic states GLU-AC (mg/dL) HbA1c (%)
94.5 ± 3.8
140.3 ± 44.2 <0.0001****
5.5 ± 0.3
6.6 ± 1
0.0002***
Values were expressed as mean ± SD (standard deviation) or percentage BMI: body mass index;GLU-AC fasting blood glucose;HbA1c Hemoglobin A1c Statistical test performed with Mann-Whitney Statistical test P<0.05 454 Table 2 The Pearson Correlation of bacterial diversity with GluAC and HbA1c Analytic results
GluAC
HbA1c
Pearson correlation
P value
N
S Genus
0.169
0.419
25
S Species
0.427*
0.033
25
G Genus
0.381
0.060
25
G Species
0.378
0.062
25
S Genus
0.134
0.523
25
S Species
0.556**
0.004
25
G Genus
0.149
0.476
25
G Species
0.275
0.183
25
*Statistical test performed with Mann-Whitney Statistical test P<0.05 S: Saliva G: gingival sulcus 455 456 457 25
Table 3 The correlation of bacterial genus in gingiva sulcus with GluAC and HbA1c in the results of MALDI BioTyper Pearson correlation
P value
N
0.592*
0.026
14
Porphyromonas spp.
0.992**
<0.01
6
Prevotella spp.
0.661*
0.014
13
Rothia spp.
0.938*
0.018
5
Veillonella spp.
0.602**
0.006
19
Porphyromonas spp.
0.893*
0.017
6
Analytic results Campylobacter spp. GluAC
HbA1c
*Significant (P<0.05) 458 Table 4 The correlation of bacterial species in saliva and gingiva sulcus with GluAC and HbA1c Pearson P value correlation
Analytic results
GluAC
HbA1c
N
S species
Prevotella melaninogenica .914*
0.03
5
G species
Campylobacter rectus
0.034
9
G species
Porphyromonas gingivalis .999**
0.001
4
G species
Streptococcus gordonii
.772**
0.009
10
G species
Streptococcus mitis
.693*
0.013
12
G species
Streptococcus salivarius
.909*
0.012
6
G species
Veillonella parvula
.518*
0.033
17
S species
Prevotella melaninogenica .959**
0.01
5
G species
Porphyromonas gingivalis .960*
0.040
4
G species
Streptococcus mitis
0.022
12
.705*
.652*
*Statistical test performed with Mann-Whitney Statistical test P<0.05 S: Saliva G: gingival sulcus 459 460
References
461 462 463
1.
464
2.
Darveau, R.P., Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol, 2010. 8(7): p. 481-90. Gao, L., et al., Oral microbiomes: more and more importance in oral cavity and whole body. 2018. 9(5): p. 488-500. 26
465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487
3.
He, J., et al., The oral microbiome diversity and its relation to human diseases.
4.
Folia Microbiol (Praha), 2015. 60(1): p. 69-80. Kocher, T., et al., Periodontal complications of hyperglycemia/diabetes mellitus: Epidemiologic complexity and clinical challenge. Periodontol 2000,
5.
6. 7.
8.
9. 10. 11. 12.
2018. 78(1): p. 59-97. Demmer, R.T., et al., The subgingival microbiome, systemic inflammation and insulin resistance: The Oral Infections, Glucose Intolerance and Insulin Resistance Study. J Clin Periodontol, 2017. 44(3): p. 255-265. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2019. Diabetes Care, 2019. 42(Suppl 1): p. S61-s70. Lee, J.E., Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol. Ann Pediatr Endocrinol Metab, 2015. 20(2): p. 74-8. Chopra, P. and T.S. Kumar, Correlation of glucose level among venous, gingival and finger-prick blood samples in diabetic patients. J Indian Soc Periodontol, 2011. 15(3): p. 288-91. Ficara, A.J., et al., A comparison of the glucose and protein content of gingival fluid from diabetics and nondiabetics. J Periodontal Res, 1975. 10(3): p. 171-5. Longo, P.L., S. Dabdoub, and P. Kumar, Glycaemic status affects the subgingival microbiome of diabetic patients. J Clin Periodontol., 2018. Ganesan, S.M., et al., A tale of two risks: smoking, diabetes and the subgingival microbiome. ISME J, 2017. 11(9): p. 2075-2089. Aemaimanan, P., P. Amimanan, and S. Taweechaisupapong, Quantification of
488 489
key periodontal pathogens in insulin-dependent type 2 diabetic and non-diabetic patients with generalized chronic periodontitis. Anaerobe, 2013.
490 491
22: p. 64-8. Casarin, R.C., et al., Subgingival biodiversity in subjects with uncontrolled
492 493 494 495 496
13.
14.
type-2 diabetes and chronic periodontitis. J Periodontal Res, 2013. 48(1): p. 30-6. Sbordone, L., et al., Periodontal status and subgingival microbiota of insulin-dependent juvenile diabetics: a 3-year longitudinal study. J Periodontol, 1998. 69(2): p. 120-8.
497 498 499
15.
Zhou, M., et al., Investigation of the effect of type 2 diabetes mellitus on subgingival plaque microbiota by high-throughput 16S rDNA pyrosequencing. PLoS One, 2013. 8(4): p. e61516.
500 501 502
16.
Yuan, K., et al., Detection of putative periodontal pathogens in non-insulin-dependent diabetes mellitus and non-diabetes mellitus by polymerase chain reaction. J Periodontal Res, 2001. 36(1): p. 18-24. 27
503 504 505 506 507 508 509 510 511 512 513 514
17.
Campus, G., et al., Diabetes and periodontal disease: a case-control study. J
18.
Periodontol, 2005. 76(3): p. 418-25. Hintao, J., et al., The microbiological profiles of saliva, supragingival and subgingival plaque and dental caries in adults with and without type 2
19.
20.
diabetes mellitus. Oral Microbiol Immunol, 2007. 22(3): p. 175-81. Sardi, J.C., et al., Periodontal conditions and prevalence of putative periodontopathogens and Candida spp. in insulin-dependent type 2 diabetic and non-diabetic patients with chronic periodontitis--a pilot study. Arch Oral Biol, 2011. 56(10): p. 1098-105. Field, C.A., et al., Investigation and quantification of key periodontal pathogens in patients with type 2 diabetes. J Periodontal Res, 2012. 47(4): p. 470-8.
515 516 517
21.
Bhatti, M.M., et al., Rapid identification of positive blood cultures by matrix-assisted laser desorption ionization-time of flight mass spectrometry using prewarmed agar plates. J Clin Microbiol, 2014. 52(12): p. 4334-8.
518 519 520 521
22.
Haiko, J., et al., Identification of urinary tract pathogens after 3-hours urine culture by MALDI-TOF mass spectrometry. J Microbiol Methods, 2016. 129: p. 81-4. Turvey, M.E., et al., Identification of beer spoilage microorganisms using the
522 523 524 525 526 527
23.
24.
25.
MALDI Biotyper platform. Appl Microbiol Biotechnol, 2016. 100(6): p. 2761-73. Samb-Ba, B., et al., MALDI-TOF identification of the human Gut microbiome in people with and without diarrhea in Senegal. PLoS One, 2014. 9(5): p. e87419. Jang, K.S. and Y.H. Kim, Rapid and robust MALDI-TOF MS techniques for microbial identification: a brief overview of their diverse applications. J Microbiol, 2018. 56(4): p. 209-216.
528 529
Harder, S., et al., Analysis of the intraimplant microflora of two-piece dental implants. Clin Oral Investig, 2013. 17(4): p. 1135-42. Seng, P., et al., Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis., 2009(1537-6591 (Electronic)).
530 531 532 533 534
26.
535 536 537
28.
Patel, R., Matrix-assisted laser desorption ionization-time of flight mass spectrometry in clinical microbiology. Clin Infect Dis., 2013(1537-6591 (Electronic)).
538 539 540
29.
Cherkaoui, A., et al., Comparison of two matrix-assisted laser desorption ionization-time of flight mass spectrometry methods with conventional phenotypic identification for routine identification of bacteria to the species
27.
28
level. J Clin Microbiol, 2010. 48(4): p. 1169-75.
541 542 543 544 545 546 547 548 549 550 551 552 553 554 555
30. 31. 32.
33.
34. 35.
556 557 558 559
36.
560 561 562 563
38.
564 565
37.
39.
40.
Singhal, N., et al., MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis. Front Microbiol, 2015. 6: p. 791. Decristophoris, P., et al., Identification of Staphylococcus intermedius Group by MALDI-TOF MS. Syst Appl Microbiol, 2011. 34(1): p. 45-51. Schulthess, B., et al., Use of the Bruker MALDI Biotyper for identification of molds in the clinical mycology laboratory. J Clin Microbiol, 2014. 52(8): p. 2797-803. Schulthess, B., et al., Evaluation of the Bruker MALDI Biotyper for identification of Gram-positive rods: development of a diagnostic algorithm for the clinical laboratory. J Clin Microbiol, 2014. 52(4): p. 1089-97. Tanner, A.C., Anaerobic culture to detect periodontal and caries pathogens. J Oral Biosci, 2015. 57(1): p. 18-26. Kaczor-Urbanowicz, K.E., et al., Salivary exRNA biomarkers to detect gingivitis and monitor disease regression. 2018. 45(7): p. 806-817. Shannon, C.E., A mathematical theory of communication. Bell system technical journal, 1948. 27(3): p. 379-423. Clarke, K.R., et al., Change in marine communities: an approach to statistical analysis and interpretation. 2014: Primer-E Ltd. Magurran, A.E., Ecological diversity and its measurement. 1988: Princeton university press. Taylor, J.J., P.M. Preshaw, and E. Lalla, A review of the evidence for pathogenic mechanisms that may link periodontitis and diabetes. J Clin Periodontol, 2013. 40 Suppl 14: p. S113-34. Makiura, N., et al., Relationship of Porphyromonas gingivalis with glycemic level in patients with type 2 diabetes following periodontal treatment. Oral Microbiol Immunol, 2008. 23(4): p. 348-51.
566 567
Paster, B.J., et al., Bacterial diversity in human subgingival plaque. J Bacteriol, 2001. 183(12): p. 3770-83. Tervonen, T., et al., Prevalence of periodontal pathogens with varying metabolic control of diabetes mellitus. J Clin Periodontol, 1994. 21(6): p. 375-9.
568 569 570 571 572
41.
573 574 575
43.
Haffajee, A.D., et al., Subgingival microbiota of chronic periodontitis subjects from different geographic locations. J Clin Periodontol, 2004. 31(11): p. 996-1002.
576 577 578
44.
Kim, T.S., et al., Differences in subgingival microflora of Korean and German periodontal patients. Arch Oral Biol, 2009. 54(3): p. 223-9. Valentine, N., et al., Effect of culture conditions on microorganism
42.
45.
29
579
identification
580 581 582
spectrometry. Appl Environ Microbiol, 2005. 71(1): p. 58-64. Carbonnelle, E., et al., Rapid identification of Staphylococci isolated in clinical microbiology laboratories by matrix-assisted laser desorption ionization-time
583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603
46.
47.
48.
49. 50.
51.
by
matrix-assisted
laser
desorption
ionization
mass
of flight mass spectrometry. J Clin Microbiol, 2007. 45(7): p. 2156-61. Stingu, C.S., et al., Rapid identification of oral Actinomyces species cultivated from subgingival biofilm by MALDI-TOF-MS. J Oral Microbiol, 2015. 7: p. 26110. Stingu, C.S., et al., Rapid identification of oral anaerobic bacteria cultivated from subgingival biofilm by MALDI-TOF-MS. Oral Microbiol Immunol, 2008. 23(5): p. 372-6. Veloo, A.C., G.W. Welling, and J.E. Degener, The identification of anaerobic bacteria using MALDI-TOF MS. Anaerobe, 2011. 17(4): p. 211-2. Yeh, H.C., et al., Identification of microbiota in peri-implantitis pockets by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Sci Rep, 2019. 9(1): p. 774. Socransky, S.S., et al., Use of checkerboard DNA-DNA hybridization to study complex microbial ecosystems. Oral Microbiol Immunol, 2004. 19(6): p. 352-62.
53.
Shibli, J.A., et al., Composition of supra- and subgingival biofilm of subjects with healthy and diseased implants. Clin Oral Implants Res, 2008. 19(10): p. 975-82. Persson, G.R. and S. Renvert, Cluster of bacteria associated with
54.
peri-implantitis. Clin Implant Dent Relat Res, 2014. 16(6): p. 783-93. Veloo, A.C., et al., Comparison of two matrix-assisted laser desorption
52.
604 605
ionisation-time of flight mass spectrometry methods for the identification of clinically relevant anaerobic bacteria. Clin Microbiol Infect, 2011. 17(10): p.
606 607 608 609 610
1501-6. De Carolis, E., et al., Development and validation of an in-house database for matrix-assisted laser desorption ionization-time of flight mass spectrometry-based yeast identification using a fast protein extraction procedure. J Clin Microbiol, 2014. 52(5): p. 1453-8.
611 612 613
55.
56.
Kaczor-Urbanowicz, K.E., et al., Novel approaches for bioinformatic analysis of salivary RNA sequencing data for development. Bioinformatics, 2018. 34(1): p. 1-8.
614
30
a 3
Saliva *
2.5 2 1.5 1 0.5 0
Diversity of Diversity of Genus Species Glycemic states (mg/dL) <100 >100
Shannon's diversity index
Shannon's diversity index
b 3 2.5
Gingival sulcus **
2 1.5 1 0.5 0
Diversity of Diversity of Genus Species Glycemic states (mg/dL) <100 >100
Figure 1
Diversity of Species
Diversity of Genus
b
Saliva
a
f
d
e
h
c
g
GluAC
Diversity of Genus
HbA1c
Diversity of Species
Gingival sulcus
Figure 2
GluAC
Figure 3
GluAC
Figure 4
GluAC
Figure 5
10^2
GluAC
Figure 6